Net income of ABIOMED under GAAP for 9 months of fiscal year 2022 was $76.18 million, down 2.2 times from $168.669 million in the previous year. Revenue increased 25.7% to $761.903 million from $606.277 million a year earlier.
Net income of ABIOMED under GAAP for 9 months of fiscal year 2022 was $76.18 million, down 2.2 times from $168.669 million in the previous year. Revenue increased 25.7% to $761.903 million from $606.277 million a year earlier. 
investors.abiomed.com
English (US) 